West Pharmaceutical Services (WST) Inventory (2009 - 2026)

West Pharmaceutical Services (WST) has reported Inventory for 18 consecutive years, with $447.4 million the latest figure, recorded in Q2 2026.

• Quarterly Inventory rose 6.25% year-over-year to $447.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $447.4 million (up 6.25% YoY) and the FY2025 annual result came in at $443.9 million, up 17.75% from the prior year.
• Inventory declined to $447.4 million in Q2 2026 per WST's latest filing, from $452.6 million in the prior quarter.
• Over the last five years, Inventory for WST reached as high as $452.6 million in Q1 2026 and fell as low as $377.0 million in Q4 2024.
• A 5-year average of $424.3 million and a median of $425.5 million in 2024 frame the typical range for Inventory.
• Annual changes were most pronounced in 2022 — Inventory soared 34.27% — and 2024, when it dropped 13.27%.
• Year by year, Inventory stood at $414.8 million in 2022, then advanced by 4.8% to $434.7 million in 2023, then declined by 13.27% to $377.0 million in 2024, then increased by 17.75% to $443.9 million in 2025, then increased by 0.79% to $447.4 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $447.4 million, $452.6 million, and $443.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.